Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

Share Price is delayed by 15 minutes
Get Live Data
889.00    3.50 (0.40%)
Bid:
889.50
Ask:
891.00
Spread: 1.50 (0.169%)
Market Cap: £1.37b
ATYM Live PriceLast checked at - London Stock Exchange

Intraday Atalaya Mining Share Chart

Incentive Options Scheme

2 May 2006 07:01

Eastern Mediterranean Res. Pblc LD02 May 2006 AIM: EMED 2 May 2006 EMED INCENTIVE OPTIONS SCHEME Eastern Mediterranean Resources Public Ltd ("EMED") today updates shareholdersof its incentive options scheme and of the issuance of new options to Managementand Directors. Current participation limits and levels are as follows: • Options on issue, 16.5 million versus 17.6 million permissible based on issued capital 70.4 million shares • 3.9 million issued in April 2006 to Officers exercisable at 13.5p per share, being a 15% premium to market • Incentive Options held by Management and Directors or their associates are now as follows: • Mr Anagnostaras-Adams, Managing Director, 6,500,000 of which 1,500,000 are New Options • Mr Cunneen, Head of Exploration, 1,850,000 of which 350,000 are New Options • Dr Constantinides, Head of Development, 800,000 of which 300,000 are New Options • Other Managers, 3,836,000 of which 1,296,000 are New Options • Mr Gordon Toll, Chairman of Directors, 1,450,000 of which 200,000 are New Options • Mr Ronnie Beevor, Non-Executive Director, 1,450,000 of which 200,000 are New Options • Dr Andreas Panayiotou, Non-Executive Director, 725,000 of which 100,000 are New Options Governance of Incentive Scheme • Scheme established at the time of the Company's ordinary Shares being admitted to AIM in May 2005. • The ethos of the scheme is to appropriately incentivise and reward Managers and Directors • Remuneration Committee administers the scheme, advised by Nominated Advisers and legal advisers • Scheme and participation levels normally to be reviewed annually after Company AGM Number of Options • To recognise that remuneration levels are unchanged since Company Admission to AIM and are not high by industry standards • Normally to number no more than twenty per cent (20.0%) of the fully-diluted issued share capital • The maximum limit will decrease as the overall value of EMED increases. By way of illustration once EMED has a market capitalisation of £100 million, the percentage would be circa ten per cent (10.0%). Exercise Periods, Price and Vesting • Normally have exercise periods of six years and vest in 3 equal instalments over the first 2 years • Should be fixed between the prevailing market price at the time of issue and up to 20% premium to market Managing Director Harry Anagnostaras-Adams said, "EMED has started as a smallexploration company, dedicated to a bold mission of establishing a profitablemining house by discovering or buying copper or gold deposits in the Eurasianregion. At this stage our key asset is our people and we are fortunate to haveassembled such an excellent team." EnquiriesEastern Mediterranean Resources Nabarro Wells Parkgreen CommunicationsHarry Anagnostaras-Adams David Nabarro Ana Ribeiro+357 9945 7843 +44 (0) 20 7710 7400 +44 (0) 20 7493 3713www.emed-resources.com www.emed.tv This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Oct 20184:35 pmRNSPrice Monitoring Extension
12th Oct 20187:00 amRNSRecent press speculation
10th Oct 20187:00 amRNSThird Quarter 2018 Operations Update
26th Sep 20187:00 amRNSReceipt of Ruling of EeA Claim
12th Sep 20187:00 amRNSQ2 and H1 2018 Interim Financial Statements
30th Jul 20187:00 amRNSNI 43-101 Technical Report for Proyecto Riotinto
16th Jul 20187:00 amRNSSecond Quarter 2018 Operations Update
9th Jul 20187:00 amRNSProyecto Riotinto updated 43-101 technical report
27th Jun 201811:41 amRNSResult of AGM
27th Jun 20187:00 amRNSAGM Statement
1st Jun 20181:37 pmRNSIssue of Equity
30th May 20187:00 amRNSNotice of AGM
24th May 20187:00 amRNS1st Quarter Financial Results
21st May 20187:00 amRNSFiling of Pre-Feasibility Study for Proyecto Touro
27th Apr 201810:03 amRNSAudited Financial Statements
23rd Apr 20187:00 amRNSProyecto Touro Pre-feasibility Study
13th Apr 20187:00 amRNSIssue of Equity - Buyout of Rumbo Royalty
11th Apr 20187:00 amRNSFirst quarter 2018 Operations Update
27th Mar 20187:00 amRNSResults for the year ended 31 December 2017
13th Feb 20187:00 amRNSIssue of Equity
22nd Jan 20187:00 amRNS2017 Operations Update and 2018 Guidance
7th Dec 201710:55 amRNSResult of Equity Issue
4th Dec 20177:05 amRNSProposed Placing to raise up to £39 million
4th Dec 20177:01 amRNSApproval of Expansion Project at Proyecto Riotinto
16th Nov 20177:00 amRNS3rd Quarter Financial Results
12th Oct 20177:00 amRNS3rd Quarter Operations Update
7th Sep 20177:00 amRNSHalf-year Report
31st Jul 20177:00 amRNSSecond quarter operations update
13th Jul 20171:05 pmRNSResult of AGM
13th Jul 20179:00 amRNSAGM Statement
15th Jun 20177:00 amRNSNotice of AGM
9th Jun 201712:10 pmRNSDirector/PDMR Shareholding Replacement
9th Jun 201711:20 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSProyecto Touro - Progress update
2nd Jun 20177:00 amRNSProyecto Riotinto production study to proceed
25th May 20177:00 amRNS1st Quarter Results
20th Apr 20177:00 amRNSFirst Quarter 2017 Operations Update
6th Apr 20177:00 amRNSFinal Results
6th Mar 201711:46 amRNSAstor Management AG case update
2nd Mar 20177:00 amRNSGranting of Share Options
23rd Feb 20177:00 amRNSOption to acquire Touro Copper Project interest
3rd Feb 20177:00 amRNSAstor Management AG litigation case update
17th Jan 20177:00 amRNS2016 Operations Update
19th Dec 20167:00 amRNSNameplate Capacity Achieved
24th Nov 20167:00 amRNSOperational Review and Q3 Financials
11th Oct 20167:00 amRNSOperations Update
29th Sep 20164:05 pmRNSFiling of NI 43-101 Technical Report
7th Sep 20167:00 amRNSHalf-year Report
5th Sep 20167:00 amRNSUS$14 million Prepayment Funding with Transamine
25th Jul 20167:00 amRNSOperations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.